Surgery Partners (SGRY) PT Lowered to $31 at Barclays
Barclays analyst Andrew Mok lowered the price target on Surgery Partners (NASDAQ: SGRY) to $31.00 (from $32.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
